In an open-label Brazilian trial of adults with HTLV-1, dolutegravir vs vitamin C led to higher physical quality-of-life (RAND-36 PCS) scores at 96 weeks (adjusted mean difference 3.92; 95% CI 0.30–7.53) among 61 completers; mental scores did not differ.
RCTn = 61
Lins-Kusterer et al. Dolutegravir improves physical health-related quality of life in adults with HTLV-1 infection: A randomized controlled trial